1 |
袁大巍,克力木,张成,等.胃食管反流病的精准诊断与个体化治疗的进展[J/CD].中华胃食管反流病电子杂志, 2016, 3(1): 27.
|
2 |
Indonesian Society of Gastroenterology. National consensus on the management of gastroesophageal reflux disease in Indonesia [J]. Acta Med Indones, 2014, 46(3): 263-271.
|
3 |
Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease [J]. Am J Gastroenterol, 2013, 108(3): 308-328.
|
4 |
Eusebi LH, Ratnakumaran R, Yuan Y, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis [J]. Gut, 2018, 67(3): 430-440.
|
5 |
Böhmer AC, Schumacher J. Insights into the genetics of gastroesophageal reflux disease (GERD) and GERD-related disorders [J]. Neurogastroenterol Motil, 2017, 29(2). doi: 10.1111/nmo.13017.
|
6 |
Ye J. Mechanisms of insulin resistance in obesity [J]. Front Med, 2013, 7(1): 14-24.
|
7 |
Huang PL. A comprehensive definition for metabolic syndrome [J]. Dis Model Mech, 2009, 2(5-6): 231-237.
|
8 |
Wilcox G. Insulin and Insulin Resistance [J]. Clin Biochem Rev, 2005, 26(2): 19-39.
|
9 |
Park JH, Park DI, Kim HJ, et al. Metabolic syndrome is associated with erosive esophagitis [J]. World J Gastroentero, 2008, 14(35):5442-5447.
|
10 |
Wu P, Ma L, Dai G X, et al. The association of metabolic syndrome with reflux esophagitis: a case-control study [J]. Neurogastroenterol Motil, 2011, 23(11): 989-994.
|
11 |
Punjabi P, Hira A, Prasad S, et al. Review of gastroesophageal reflux disease (GERD) in the diabetic patient [J]. J Diabetes, 2015, 7(5): 599-609.
|
12 |
Dong LS, Bora K, Jai CH, et al. Gastroesophageal Reflux Disease in Type II Diabetes Mellitus With or Without Peripheral Neuropathy [J]. J Neurogastroenterol Motil, 2011, 17(3): 274-278.
|
13 |
Krishnan B, Babu S, Walker J, et al. Gastrointestinal complications of diabetes mellitus [J]. World J Diabetes, 2013, 4(3): 51-63.
|
14 |
Rayner CK, Samsom M, Jones KL, et al. Relationships of upper gastrointestinal motor and sensory function with glycemic control [J]. Diabetes Care, 2001, 24(2): 371-381.
|
15 |
Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome [J]. Endocr Pract, 2003, 9(3): 237-252.
|
16 |
Nam SY, Choi IJ, Ryu KH, et al. The effect of abdominal visceral fat, circulating inflammatory cytokines, and leptin levels on reflux esophagitis [J]. J Neurogastroenterol Motil, 2015, 21(2): 247-254.
|
17 |
Rieder F, Biancani P, Harnett K, et al. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis [J]. Am J Physiol Gastrointest Liver Physiol, 2010, 298(5): G571-581.
|
18 |
Tai CM, Lee YC, Tu HP, et al. The relationship between visceral adiposity and the risk of erosive esophagitis in severely obese chinese patients [J]. Obesity, 2010, 18(11): 2165-2169.
|
19 |
Di Caro S, Cheung WH, Fini L, et al. Role of body composition and metabolic profile in Barrett’s oesophagus and progression to cancer [J]. Eur J Gastroenterol Hepatol, 2016, 28(3): 251-260.
|
20 |
Pointer SD, Rickstrew J, Slaughter JC, et al. Dietary carbohydrate intake, insulin resistance and gastro-oesophageal reflux disease: a pilot study in European-and African-American obese women [J]. Aliment Pharmacol Ther, 2016, 44(9): 976-988.
|
21 |
Fujiwara M, Eguchi Y, Fukumori N, et al. The Symptoms of Gastroesophageal Reflux Disease Correlate with High Body Mass Index, the Aspartate Aminotransferase/Alanine Aminotransferase Ratio and Insulin Resistance in Japanese Patients with Non-alcoholic Fatty Liver Disease [J]. Intern Med, 2015, 54(24): 3099-3104.
|
22 |
Clayton S., Cauble E., Kumar A., Patil N., Ledford D., Kolliputi N., … Richter J. (2019). Plasma levels of TNF-α, IL-6, IFN-γ, IL-12, IL-17, IL-22, and IL-23 in achalasia, eosinophilic esophagitis (EoE), and gastroesophageal reflux disease (GERD). BMC Gastroenterology, 19(1).doi: 10.1186/s12876-019-0937-9
|
23 |
Morino K, Petersen KF, Shulman GI. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction [J]. Diabetes, 2006, 55 Suppl 2: S9-S15.
|
24 |
Saini V. Molecular mechanisms of insulin resistance in type 2 diabetes mellitus [J]. World J Diabetes, 2010, 1(3): 68-75.
|
25 |
Savage DB, Petersen KF, Shulman GI. Mechanisms of insulin resistance in humans and possible links with inflammation [J]. Hypertension, 2005, 45(5): 828-833.
|
26 |
Fernandez-Real JM, Vayreda M, Richart C, et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women [J]. J Clin Endocrinol Metab, 2001, 86(3): 1154-1159.
|
27 |
Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance [J]. Febs Letters, 2006, 582(1): 1922.
|